Table 1 Patients’ demographic and clinical characteristics
Parameters | Patients (n) N = 74 | ||
|---|---|---|---|
N | % | ||
Age, years | ≥ 55 | 53 | 71.6% |
|  | < 55 | 21 | 28.4% |
Gender | Male | 59 | 79.73% |
| Â | Female | 15 | 20.27% |
AFP (pre) | ≥ 20 ng/mL | 26 | 35.14% |
|  | < 20 ng/mL | 48 | 64.86% |
ALT (pre) | ≥ 40 U/L | 14 | 18.92% |
|  | < 40 U/L | 59 | 79.73% |
| Â | no detection | 1 | 1.35% |
AST (pre) | ≥ 40 U/L | 13 | 17.57% |
|  | < 40 U/L | 60 | 81.08% |
| Â | no detection | 1 | 1.35% |
HBV | positive | 24 | 32.43% |
| Â | negative | 49 | 66.22% |
| Â | no detection | 1 | 1.35% |
Tumor size | < 3 cm | 42 | 56.76% |
|  | ≥ 3 and < 5 cm | 13 | 17.57% |
|  | ≥ 5 cm | 19 | 25.68% |
Tumor count | multiple | 12 | 16.22% |
| Â | single | 62 | 83.78% |
Tumor encapsulation | yes | 44 | 59.46% |
| Â | no | 30 | 40.54% |
Tumor differentiation | well | 5 | 6.76% |
| Â | medium | 60 | 81.08% |
| Â | poor | 7 | 9.46% |
| Â | unknown | 2 | 2.70% |
MVI | 0 | 59 | 79.73% |
| Â | 1 | 13 | 17.57% |
| Â | 2 | 2 | 2.70% |
BCLC stage | 0 | 17 | 22.97% |
| Â | A | 47 | 63.51% |
| Â | B | 5 | 6.76% |
| Â | C | 5 | 6.76% |
Child-Pugh score | A | 73 | 98.65% |
| Â | unknown | 1 | 1.35% |
TACE treatment | yes | 16 | 21.62% |
| Â | no | 58 | 78.38% |
Primary | yes | 52 | 70.27% |
| Â | no | 22 | 29.73% |
Drinking history | yes | 25 | 33.78% |
| Â | no | 49 | 66.22% |
Smoking history | yes | 28 | 37.84% |
| Â | no | 46 | 62.16% |